PharmAust (ASX:PAA) Share Price and News - StockTrack

Market Cap (17-Dec) $111,926,056 (1,449th)	Close (30-Jun) $0.075 0 (0%)	Volume (30-Jun) 0	Shortsold (11-Oct) 108,089 (0.02%) (492nd)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.02

	Subject
	PAA PAA Ann: MND Trial Completes Enrolment of First Patient Cohort
	1 (current) 2 3
	PAA PAA Ann: Results of Annual General Meeting
	PAA PAA Ann: AGM Presentation
	PAA PAA Ann: Epichem webinar presentation
	PAA PAA Ann: DNDi contract extension for PharmAust subsidiary Epichem
	PAA PAA Ann: Investor Webinar
	PAA PAA Ann: Appendix 4C and Quarterly Update
	PAA PAA Ann: First Patient Dosed in MND Phase 1/2 Trial
	PAA PAA Ann: Notice of Annual General Meeting/Proxy Form
	PAA PAA Ann: Change of Director's Interest Notice
	PAA PAA Ann: First Patient in US Canine Cancer Trials Begins Treatment
	PAA PAA Ann: Appendix 4G & Corporate Governance Statement
	PAA PAA Ann: Appendix 4E & Full Year Statutory Accounts
	PAA PAA Ann: Update on PharmAust Canine Cancer Trials
	PAA PAA Ann: Appendix 4C and Quarterly Update
	PAA PAA Ann: Notification of cessation of securities - PAA
	PAA PAA Ann: Science Week Conference Presentation
	PAA PAA Ann: Fiona Milner appointed Epichem General Manager
	PAA PAA Ann: Resignation of Dr Richard Mollard
	PAA PAA Ann: PharmAust Clinical Trials Update
	PAA PAA Ann: PharmAust receives $210k prepayment of forecast R&D rebate
	PAA PAA Ann: MPL tablets arrive in Melbourne for MND Clinical Trial
	PAA PAA Ann: PharmAust Expands Lymphoma Canine Trial to the USA
	PAA PAA Ann: Notification of cessation of securities - PAA
	PAA PAA Ann: Appendix 4C and Quarterly Update
	PAA PAA Ann: PharmAust Receives $708k R&D Tax Incentive Refund
	PAA PAA Ann: PAA appoints trial manager & receives $200k from FightMND
	PAA PAA Ann: Notification of cessation of securities - PAA
	PAA PAA Ann: MPL manufactured and tableting commenced
	PAA PAA Ann: Preliminary MPL antiviral leukaemia preclinical WEHI results
	PAA PAA Ann: Key Appointment to Progress MPL COVID-19 Clinical Trial
	PAA PAA Ann: Appendix 4D & Half Year Report
	PAA PAA Ann: Epichem Confirms Effectiveness of OHD E-Waste Project
	PAA PAA Ann: Resignation of Epichem CEO
	PAA PAA Ann: Update on Manufacture of MPL & Tablets for Clinical Trials
	PAA PAA Ann: Appendix 4C and Quarterly Update
	PAA PAA Ann: Epichem Awarded Contract Extension from DNDi
	PAA PAA Ann: Shareholder Update - Progress and Strategy
	PAA PAA Ann: Demonstration batch of smaller size MPL tablets completed
	PAA PAA Ann: MND & COVID-19 Phase 1 Clinical Trials On-Track
	PAA PAA Ann: Cleansing Notice
	PAA PAA Ann: Application for quotation of securities - PAA
	PAA PAA Ann: Canine phase 2b cancer trial expands to New Zealand
	PAA PAA Ann: JobKeeper Payment Notification
	PAA PAA Ann: Change of Director's Interest Notice x 4
	PAA PAA Ann: PAAO Top 20 Holders & Distribution Schedule
	PAA PAA Ann: Application for quotation of securities - PAA
	PAA PAA Ann: Closure of Entitlement Offer
	PAA PAA Ann: Appendix 4C and Quarterly Update
	PAA PAA Ann: Results of Annual General Meeting

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
16-Dec	$0.17	882,169	-0.02 (8.33%)
13-Dec	$0.18	127,632	-0.01 (2.70%)
12-Dec	$0.19	382,091	+0.01 (5.71%)
11-Dec	$0.18	620,427	0.00 (0.00%)
09-Dec	$0.18	105,356	+0.00 (2.94%)
06-Dec	$0.17	261,837	+0.01 (6.25%)
05-Dec	$0.16	889,407	-0.02 (11.11%)
03-Dec	$0.18	65,135	+0.01 (2.86%)
02-Dec	$0.18	490,456	-0.01 (5.41%)
29-Nov	$0.19	163,628	+0.01 (5.71%)
28-Nov	$0.18	217,540	0.00 (0.00%)
27-Nov	$0.18	1,424,745	-0.01 (5.41%)
26-Nov	$0.19	414,413	-0.01 (2.63%)
25-Nov	$0.19	308,103	0.00 (0.00%)
22-Nov	$0.19	750,714	0.00 (0.00%)
5 up, 6 down, and 4 flat days

High -	Low -	Trades -	Turnover $0	Volume 0
5 June 2026 at 4:30am

High -	Low -	Trades -	Turnover $0	Volume 0
5 June 2026 at 4:30am

PharmAust Health Care

$0.075 (0%)

$0.075 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices